scholarly journals Executive function in children with Tourette syndrome and attention-deficit/hyperactivity disorder: Cross-disorder or unique impairments?

Cortex ◽  
2020 ◽  
Vol 124 ◽  
pp. 176-187 ◽  
Author(s):  
Thaïra J.C. Openneer ◽  
Natalie J. Forde ◽  
Sophie E.A. Akkermans ◽  
Jilly Naaijen ◽  
Jan K. Buitelaar ◽  
...  
1995 ◽  
Vol 1 (6) ◽  
pp. 511-516 ◽  
Author(s):  
Emily L. Harris ◽  
Linda J. Schuerholz ◽  
Harvey S. Singer ◽  
Mark J. Reader ◽  
Janice E. Brown ◽  
...  

AbstractTourette Syndrome (TS) in children is associated with various neurobehavioral disorders including attention deficit hyperactivity disorder (ADHD). Children with TS and ADHD show some difficulties with neuropsychological tasks, but we do not know if children with TS alone have neuropsychological deficits. To assess specific cognitive differences among children with TS and/or ADHD, we administered a battery of neuropsychological tests, including 10 tasks related to executive function (EF), to 10 children with TS-only, 48 with ADHD-only, and 32 with TS+ADHD. Children in all groups could not efficiently produce output on a timed continuous performance task [Test of Variables of Attention (TOVA) mean reaction time and reaction time variability]. Children with TS-only appeared to have fewer EF impairments and significantly higher perceptual organization scores than children with TS+ADHD or ADHD-only. These findings suggest that deficiencies in choice reaction time and consistency of timed responses are common to all three groups, but children with TS-only have relatively less EF impairment than children with TS+ADHD or ADHD-only. (JINS, 1995, 1, 511–516.)


CNS Spectrums ◽  
2008 ◽  
Vol 13 (4) ◽  
pp. 301-303 ◽  
Author(s):  
Jessica Sears ◽  
Nitin C. Patel

ABSTRACTTics and Tourette syndrome are common comorbidities of patients diagnosed with attention-deficit/hyperactivity disorder (ADHD). One of the mainstay pharmacologic therapies for ADHD has been stimulants. However, this class of drugs has been associated with tic exacerbations, thus limiting their utility in this patients subgroup. Atomoxetine has been explored as an alternative treatment as one of the few non-stimulants available to treat ADHD. Early data identifies atomoxetine's influence on Tourette symptomatology to be not merely equivocal but potentially suppressive in the manifestation of tics. There are, however, case studies describing patients experiencing recurrences of tics following treatment with atomoxetine. We present a unique case of a patient, without any prior history of a movement disorder, who developed tics following a single dose of atomoxetine that did not improve until interventional therapy was initiated.


2015 ◽  
Vol 28 (3) ◽  
pp. 544-553 ◽  
Author(s):  
Eva Angelina Araujo Jiménez ◽  
María Claustre Jané Ballabriga ◽  
Albert Bonillo Martin ◽  
Francisco Javier Arrufat

Sign in / Sign up

Export Citation Format

Share Document